Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.
Compared with younger women, older women who undergo combined surgery for pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are almost twice as likely to experience SUI (but not POP) treatment failure.
However, older women report just as significant an improvement in symptoms and effect on quality of life as younger women do, according to the findings of a retrospective cohort study involving 122 women younger than 65 years of age and 70 women 65 years of age or older.
After a median follow-up time of almost 1 year, no significant difference existed between the 2 groups.
Twenty-one percent of the older women and 11% of the younger women reported SUI treatment failure (adjusted odds ratio [AOR], 1.10; 95% confidence interval [CI], 1.05-2.5), whereas 13% of the older women and 9% of the younger women reported POP treatment failure (AOR, 0.90; 95% CI, 0.29-2.8).
Sung VW, Joo K, Marques F, Myers DL. Patient-reported outcomes after combined surgery for pelvic floor disorders in older compared to younger women. Am J Obstet Gynecol. 2009;201(5):534. e1-e5.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More